@DrAbdulRazak_MD @tayyabaaamir9 @NICU_Musings @HebertAudrey3 @EBNEO @souvik_neo @draloksharma74 @dr_montasser @rehman_naveed @BeenaDoc @natetexsun Agree that for given scenario, existing evidence is insufficient to determine if Naloxone will confer any imp
A lot of us, me included, were taught that we needed to be aggressive with naloxone in babies, but that’s dangerous. If your protocols say to Narcan newborns, I just want to talk to your medical director. 👀 Read here to see more detail: https://t.co/bKJ
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneUK: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression due to…
RT @JveWagner: Another @CochraneNeonate review produced by @crd_york. #cochrane #SystematicReviews #evidencesynthesis https://t.co/WRx2sGHo…
RT @CochraneUK: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression due to…
Another @CochraneNeonate review produced by @crd_york. #cochrane #SystematicReviews #evidencesynthesis
RT @CochraneUK: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression due to…
RT @CochraneLibrary: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneLibrary: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneLibrary: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression due to intrauterine opioid exposure. Due to safety concerns, more RCTs needed. https://t.co/bC8eBTNBYr @CochraneSweden @Cochrane_Child @Co
RT @CochraneLibrary: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneLibrary: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneLibrary: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression due to intrauterine opioid exposure. Due to safety concerns, more RCTs needed. https://t.co/bC8eBTNBYr @CochraneSweden @Cochrane_Child @Co
RT @CochraneLibrary: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneLibrary: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneLibrary: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneLibrary: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneLibrary: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression due to intrauterine opioid exposure. Due to safety concerns, more RCTs needed. https://t.co/bC8eBTNBYr @CochraneSweden @Cochrane_Child @Co
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
@COINNEducation
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
@COINNEducation
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
RT @CochraneNeonate: Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression du…
Existing evidence insufficient for naloxone’s benefit to newborns with cardiorespiratory or neurological depression due to intrauterine opioid exposure. Due to safety concerns, more RCTs needed. https://t.co/DzoUnsPJBH @crd_york @JveWagner @CochraneSweden
JC today...use of Nalaxone in opioid exposed neonates at birth. Sadly poor quality papers & lots of bias shown. BUT summary is; ‘The existing evidence from RCTs is insufficient to determine whether naloxone confers any important benefits to newborn...
RS @cochranecollab uso de naloxona en neonatos expuestos intrautero a opioides https://t.co/24po4uRFVh Sin evidencia suficiente.
#Naloxone pour les #nouveau_nés exposés aux #opiacés : https://t.co/HJltvLU9ey
Naloxone for opioid-exposed newborn infants. https://t.co/LFD6PhVR0P